Related Experiment Videos
Candidemia in Finland, 1995-1999
Eira Poikonen1, Outi Lyytikäinen, Veli-Jukka Anttila
1Peijas Hospital, Vantaa, Finland. eira.poikonen@hus.fi
Emerging Infectious Diseases
|September 12, 2003
Summary
Candidemia (bloodstream fungal infections) incidence rose in Finland between 1995-1999, with Candida albicans remaining the most common species. Risk factors included catheters and surgery, and mortality remained high.
Area of Science:
- Infectious Diseases
- Mycology
- Epidemiology
Background:
- Candidemia, a serious bloodstream fungal infection, poses a significant public health challenge.
- Surveillance data is crucial for understanding trends and guiding prevention strategies.
Purpose of the Study:
- To analyze the incidence, species distribution, risk factors, and outcomes of candidemia in Finland from 1995 to 1999.
- To compare Finnish candidemia rates with those in the United States.
Main Methods:
- Analysis of laboratory-based surveillance data from the National Infectious Disease Register of Finland.
- Review of candidemia cases from a single tertiary-care hospital during the study period.
- Calculation of incidence rates per 100,000 population and per 1,000 patient-days.
Main Results:
- A total of 479 candidemia cases were reported, with annual incidence increasing from 1.7 to 2.2 per 100,000 population.
- Non-Candida albicans species accounted for 30% of cases, with no significant change in proportion over time.
- Key predisposing factors included indwelling catheters (81%), gastrointestinal surgery (27%), and hematologic malignancy (25%).
- Crude 7-day and 30-day case-fatality ratios were 15% and 35%, respectively.
- Candidemia rates in Finland were substantially lower than in the United States.
Conclusions:
- Candidemia incidence showed an increasing trend in Finland during the study period.
- Candida albicans remained the predominant species, with no shift towards non-albicans species observed.
- High-risk patient groups and predisposing factors were identified, highlighting areas for targeted interventions.